Press Releases
December 6 2011
November 16 2011
November 2 2011
September 16 2011
September 9 2011
July 27 2011
May 5 2011
March 3 2011
February 11 2011
February 11 2011
February 9 2011
February 2 2011
January 20 2011
January 12 2011
December 13 2010
December 1 2010
December 1 2010
November 30 2010
November 23 2010
November 3 2010
October 28 2010
October 21 2010
September 23 2010
September 22 2010
May 18 2010
October 28 2009
October 15 2009
March 31 1999
March 16 1999
March 16 1999
February 8 1999
October 27 1998
September 2 1998
March 20 1998
Letters, Testimony & Comments
March 16 2012
On behalf of BIO and its more than 1,100 members, Jim Greenwood submitted a letter to Senate Majority Leader Harry Reid and Minority Leader Mitch McConnell in strong support of H.R. 3606, the Jumpstart Our Business Startups (JOBS) Act.
March 6 2012
William D. Waddill, Senior Vice President and Chief Financial Officer of OncoMed Pharmaceuticals highlights the importance of capital formation to encourage investment in the biotechnology industry and spur job growth across the country.
December 1 2011
On December 1, BIO submitted written testimony to the Senate Committee on Banking, Housing, and Urban Affairs on the importance of implementing policies that will spur job growth through capital formation while protecting investors.
May 17 2011
BIO encourages Congress to support advanced biofuels and biobased products programs and initiatives during consideration of the Fiscal Year 2012 Energy & Water Appropriations bill. Industrial biotechnology is the key enabling technology that is causing a dramatic paradigm shift in the production of fuels and chemicals. By building modern biorefineries and using industrial biotechnology our nation could significantly reduce its dependence on foreign sources of oil.
BIO Requests for FY 2012 Agriculture, Rural Development, FDA and Related Agencies Appropriations Act
May 12 2011
BIO respectfully supports the Administration's request for a total of $2.744 billion in budget authority for the FDA and support robust funding for key programs within the U.S. Department of Agriculture.
Want to learn more about the biotech industry?
Business Solutions Sponsor
